Astria Therapeutics Inc (ATXS NASDAQ) stock market data APIs
$7.3492
0.04(0.5%)
as of September 15, 2025
Try our APIs with
free plan!
Astria Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Astria Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is navenibart, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.
Prev. Close
7.3492
Open
7.3886
High
7.7129
Low
6.9704
52 wk Range
3.555-12.92
Market Cap
416 M
Shares Outstanding
56 435 K
EPS
-0.57
Beta
0.424
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Astria Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Astria Therapeutics Inc data using free add-ons & libraries
Get Astria Therapeutics Inc Fundamental Data
Astria Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -32 380 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.49
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Astria Therapeutics Inc News
New
Shift4 Payments Becomes Oversold (FOUR)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a te...
Trump to impose tariffs on semiconductor imports from companies not moving production to the US
U.S. President Donald Trump said on Thursday that his administration would impose tariffs on semiconductor imports from companies not shifting production to the U.S. “Yeah, I have discussed it with...
2 ‘Strong Buy’ Growth Stocks Offering 300% or Higher Upside
Small-cap biotech stocks, while lacking the scale and financial stability of larger pharmaceutical giants, often have high growth potential. These companies are motivated by ground-breaking research,...
Astria Therapeutics stock price target raised to $26 by JMP on HAE program progress
Investing.com - JMP Securities raised its price target on Astria Therapeutics (NASDAQ:ATXS) to $26.00 from $25.00 on Wednesday, while maintaining a Market Outperform rating on the stock. According to ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
